Press Releases

Date	Title	Company
26-Dec-2022	CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform	CD Genomics
26-Dec-2022	CD Genomics RNA-Solutions Platform Unveils m7G MeRIP Sequencing for Scientific Research	CD Genomics
23-Dec-2022	Syringes Market to eyewitness potential growth till 2032, owing to growing demand for injectable drugs \| insightSLICE	insightSLICE
23-Dec-2022	Multiple Myeloma Market To Witness the Highest Growth Globally by Forecast to 2032 \| insightSLICE	insightSLICE
23-Dec-2022	Embolic Protection Devices Market is Estimated to Augment Growth by 2032, owing to increasing prevalence of cardiovascular diseases in developed countries \| insightSLICE	insightSLICE
23-Dec-2022	Dermatology Laser Market CAGR Values, Size, Share, SWOT Analysis by 2032 \| insightSLICE	insightSLICE
23-Dec-2022	Deep Brain Stimulation Devices Market is Projected to Booming Growth by 2032, owing to increasing incidence of neurological diseases \| insightSLICE	insightSLICE
23-Dec-2022	Bone Growth Stimulators Market is Estimated to Augment Growth by 2032, owing to increasing prevalence of bone diseases \| insightSLICE	insightSLICE
23-Dec-2022	Profacgen Enhanced Its CLIP-Seq Service for RNA-Protein Interaction Research	Profacgen
23-Dec-2022	Pareto Securities AS publishes buy recommendation for Epigenomics AG share	Epigenomics AG
23-Dec-2022	Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban	Alfa Chemistry
23-Dec-2022	CD Formulation Launches One-stop OEM/ODM and Analytical Testing Solutions for Cosmetics	CD Formulation
23-Dec-2022	Nearly 480 Cosmetic Ingredients Are Now Available at CD Formulation	CD Formulation
22-Dec-2022	InnoScot Health partner receives public service award for Right Decision Service	InnoScot Health
22-Dec-2022	Hataali and Reef Group announce strategic partnership for ATMP Smart Labs	Hataali
22-Dec-2022	10-year Moderna deal underlines UK potential for global life science leadership	Moderna
22-Dec-2022	MODERNA FINALIZES STRATEGIC PARTNERSHIP WITH UK GOVERNMENT	MODERNA
22-Dec-2022	OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas	OSE Immunotherapeutics
22-Dec-2022	OKYO Pharma Announces U.S. FDA Clearance of IND Application for OK-101 for the Treatment of Dry Eye Disease	OKYO Pharma
22-Dec-2022	Kancera submits regulatory application to conduct clinical study in ovarian cancer and enters into collaboration with the Nordic Society of Gynaecological Oncology	Kancera